Goldman Sachs’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.9M | Sell |
504,621
-1,297
| -0.3% | -$30.6K | ﹤0.01% | 2148 |
|
|
2025
Q1 | $12.2M | Sell |
505,918
-48,811
| -9% | -$1.17M | ﹤0.01% | 2083 |
|
|
2024
Q4 | $23.5M | Sell |
554,729
-45,125
| -8% | -$1.91M | ﹤0.01% | 1657 |
|
|
2024
Q3 | $26.5M | Sell |
599,854
-184,714
| -24% | -$8.16M | ﹤0.01% | 1513 |
|
|
2024
Q2 | $28.4M | Buy |
784,568
+224,778
| +40% | +$8.13M | ﹤0.01% | 1331 |
|
|
2024
Q1 | $24.1M | Sell |
559,790
-89,428
| -14% | -$3.86M | ﹤0.01% | 1416 |
|
|
2023
Q4 | $9.98M | Buy |
649,218
+229,414
| +55% | +$3.53M | ﹤0.01% | 2090 |
|
|
2023
Q3 | $5.76M | Buy |
419,804
+134,311
| +47% | +$1.84M | ﹤0.01% | 2366 |
|
|
2023
Q2 | $4.58M | Buy |
+285,493
| New | +$4.58M | ﹤0.01% | 2624 |
|
|
2021
Q3 | – | Sell |
-11,747
| Closed | -$156K | – | 5543 |
|
|
2021
Q2 | $156K | Buy |
+11,747
| New | +$156K | ﹤0.01% | 5012 |
|